Cargando…
Biological therapies for premature ovarian insufficiency: what is the evidence?
Premature Ovarian Insufficiency (POI) is a multi-factorial disorder that affects women of reproductive age. The condition is characterized by the loss of ovarian function before the age of 40 years and several factors have been identified to be implicated in its pathogenesis. Remarkably though, at l...
Autores principales: | Moustaki, Melpomeni, Kontogeorgi, Adamantia, Tsangkalova, Gkalia, Tzoupis, Haralampos, Makrigiannakis, Antonis, Vryonidou, Andromachi, Kalantaridou, Sophia N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512839/ https://www.ncbi.nlm.nih.gov/pubmed/37744287 http://dx.doi.org/10.3389/frph.2023.1194575 |
Ejemplares similares
-
Secondary diabetes mellitus in acromegaly
por: Moustaki, Melpomeni, et al.
Publicado: (2023) -
Dysregulated cytokine profile associated with biochemical premature ovarian insufficiency
por: Liu, Peihao, et al.
Publicado: (2020) -
Reverse Onco-Cardiology: What Is the Evidence for Breast Cancer? A Systematic Review of the Literature
por: Boutas, Ioannis, et al.
Publicado: (2023) -
Association of Coenzyme Q10 with Premature Ovarian Insufficiency
por: Ma, Linjuan, et al.
Publicado: (2022) -
FRI421 Immunomodulatory Therapy Can Improve Fertility In Women With Autoimmune Premature Ovarian Insufficiency - A Proof Of Concept Study
por: Hirschberg, Angelica Linden, et al.
Publicado: (2023)